COVID-19 and Return to Campus

McGill Information and resources

Faculty Information and Resources

Research Updates

Sign up to our newsletter

Sign me up

Dr. Morag Park is named to the Order of Quebec

A trailblazer, builder and innovator during a career spanning over thirty years, Dr. Park has made contributions to a wide spectrum of cancer research and now the Quebec government has appointed her Chevalière. Congratulations Dr. Park!

Research is essential for the post-pandemic recovery

Three McGill professors, Drs. Sonenberg, Fuks and Bergeron, explain how a substantial increase in budgets to the three research councils, in addition to government policies that spur entrepreneurship and innovation, will support and lead our economic and social recovery. 

Read our 2020 Annual Report

The past year has been filled with outstanding scientific achievements and major milestones in the growth and development of the Rosalind and Morris Goodman Cancer Research Centre. As reflected in our Annual Report, we continue to make
discoveries and change lives. 

Our collaborative approach is central to who we are 

Our investigators are tackling the most important problems in cancer research through innovative thinking and collaboration.

State-of-the-art technology for cancer research

Located at the heart of McGill University’s Life Sciences Complex, we are a research and training facility that has attracted leading scientists from across the world.

Laying the groundwork for new therapies

By deepening our understanding of the mechanisms behind cancer, we are providing the core knowledge with clinicians to develop new cancer treatments.

Rosalind and Morris Goodman Cancer Research Centre


The Rosalind and Morris Goodman Cancer Institute is a recognized world-class research centre, contributing to innovative developments in the treatment and ultimately the cure for cancer. This state of the art institute has energized cancer research at McGill, attracting internationally–renowned investigators. These are exciting times, with an unprecedented collaboration between clinicians and basic scientists with the shared goal of investigating the nature of cancer and metastatic disease; working together to innovate, discover and develop new treatments for cancer patients.
 

Celebrating Success

Dr. Ian Watson receives the MI4 Pfizer Early Career Investigator Award. 

 

Faculty Spotlight

Dr. Nicole Beauchemin

Dr. Nicole Beachemin has been a pioneer in the field of carcinoembryonic antigen (CEA) and has developed a robust project on defining this gene family. 

 

 

Latest Publication

Sheri McDowell from the Quail Lab published a paper in Nature Cancer  which reveals that obesity facilitates breast cancer metastasis through its effects on blood vessels and the immune system.  

Learn about our COVID-19 response below:

News

Dr. Siegel awarded major funding to develop new technologies in cancer metabolomics

21 Jun 2021
Dr. Peter Siegel is part of the 12 research teams from four Québec universities who have been awarded major funding as part of an investment of $4.5M in a new public-private partnership program called Genomics Integration Program – Human Health.
Read more

Oncolytic viruses could provide a precision medicine alternative for some hard-to-treat melanomas

14 Jun 2021
In recent years, immune checkpoint inhibitors (ICIs) have emerged as an effective treatment against melanoma. But despite their success helping patients, clinical trials have found that over half of melanoma patients either do not benefit at all or become resistant to these forms of immunotherapy.
Read more

6 Questions With Souad Mubaid

10 Jun 2021
I am from Montreal, and my family is originally from Syria. I did my undergraduate studies at McGill University studying microbiology and immunology. I then started my master’s studies and did a fast track to become a PhD candidate in the Gallouzi lab at the Rosalind and Morris Goodman Cancer Research Centre.
Read more

Sharing discoveries and building connections

20 May 2021
On May 6 and 7, 2021, more than 100 students, staff, faculty members and external guests attended the Rosalind and Morris Goodman Cancer Research Centre’s (GCRC) Research Day Symposium. Launched more than a decade ago, the event provides an annual opportunity for graduate students and post-doctoral fellows working in cancer research to present their work to their peers and the wider scientific community. Cancer researchers from external institutions are invited to speak and the event also serves as an important networking opportunity. This year’s co-organizers were Sheri McDowell, a PhD student from the Quail lab and a leader of the Equity, Diversity and Inclusion committee within the Faculty of Medicine and Health Sciences and Simon Milette, a PhD student co-supervised by Dr. Daniela Quail and Dr. Jonathan Spicer.
Read more

Awards aplenty for the GCRC

14 May 2021
The Rosalind and Morris Goodman Cancer Research Centre has had great success in receiving grants lately.
Read more

6 Questions With Amr Omer

13 May 2021
I am from Kingston, Ontario and came to Montreal to do my bachelor’s degree in biochemistry at McGill University. I am now a fifth year PhD candidate in Dr. Gallouzi’s lab.
Read more

Pages

Subscribe to Articles RSS

Cancer Institute Tweets

Back to top